Geneva, July 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600127876) titled 'A multicenter, prospective, real-world study to evaluate the efficacy and safety of fluticasone propionate nasal spray prophylaxis compared with no prophylaxis in Chinese patients with seasonal allergic rhinitis (SAR)' on July 9.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Peking Union Medical College Hospital

Condition: Seasonal allergic rhinitis

Intervention: No prevention group:Treatment period (0d to 56d, including 28 days of preventive treatment medication and 28 days of symptomatic treatment medication) The non-preventive group began to use fluticasone propionate nasal sp...